Longevity for Investors with Dr. Greg Bailey and Jess Larsen

What This Longevity Investor Knows That You Don't | Karl Pfleger, Founder of AgingBiotech.info, Co-Hosted with Dr. Greg Bailey, Chairman of Juvenescence

Jul 5, 2024
Karl Pfleger, founder of AgingBiotech.info and a former Google researcher, dives deep into the rapidly evolving longevity biotech landscape. He discusses the lucrative opportunities in aging-related investments, highlighting how targeting aging could revolutionize health care. Pfleger stresses the importance of understanding mechanisms of action and shares his investment strategies. He also emphasizes the promise of senolytics, or senescent cell clearance, as a leading frontier. For aspiring investors, he recommends diving into conferences and varied resources for informed decisions.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ADVICE

Prefer Structured Data Over Prose

  • Use sortable tables to compare companies by trial stage, modality, and subfield.
  • Prefer structured datasets over prose to speed diligence and cross-comparisons.
ANECDOTE

From Google To Building AgingBiotech.info

  • Karl left a decade at Google and moved into aging via philanthropy, then investing.
  • He built agingbiotech.info to share his company list and structured data after finding his list far larger than public roundups.
INSIGHT

Aging Is Modifiable, Not An Unchangeable Clock

  • Aging is a malleable biological process that can be slowed or reversed.
  • Treating underlying aging mechanisms could prevent many major chronic diseases before they appear.
Get the Snipd Podcast app to discover more snips from this episode
Get the app